Assembly Biosciences, Inc.(ASMB)

$26.73—

Chart

Assembly Biosciences, Inc.(ASMB)

NASDAQ

$26.73—

Chart Studio

ASMB(ASMB)

ASMB

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-0.70

Aug 5, 2026 · Reports before open

Revenue Estimate

$9M

Analyst Sentiment

Wall St. Consensus

Buy

11 analysts·Moderate coverage

Score

6 Buy (55%)5 Hold (45%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

655%

Hold

545%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$45.00

+68.4%

Consensus

$45.00

+68.4%

Bull

$45.00

+68.4%

12-Month Target Range11 analysts

$45.00$45.00$45.00

Current $26.73Consensus

Current Price

$26.73

Upside to Consensus

$18.27

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev-5.54%

EPS—

FY2028

Rev+52.33%

EPS—

FY2029

Rev-57.25%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$46M	$43M	$66M	$28M	$124M
Low	$6M	$22M	$33M	$14M	$63M
High	$85M	$71M	$108M	$46M	$204M
EBITDA Avg	$-19M	$-18M	$-27M	$-12M	$-52M
Low	$-35M	$-29M	$-45M	$-19M	$-85M
High	$-3M	$-9M	$-14M	$-6M	$-26M
EBIT Avg	$-19M	$-18M	$-27M	$-12M	$-52M
Low	$-35M	$-30M	$-45M	$-19M	$-85M
High	$-3M	$-9M	$-14M	$-6M	$-26M
Net Income Avg	$-20M	$-56M	$-32M	$-42M	$-26M
Low	$-35M	$-66M	$-60M	$-78M	$-47M
High	$-7M	$-13M	$4M	$-15M	$-9M
EPS Avg	$-1.70	$-3.21	$-2.50	$-3.78	$-2.28
Low	$-3.13	$-5.91	$-5.37	$-6.96	$-4.20
High	$-0.61	$-1.16	$0.38	$-1.36	$-0.82
Analysts (Rev / EPS)	3 / 2	3 / 2	3 / 2	2 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027
Revenue Avg	$8M	$33M	$11M	$2M	$2M	$31M
Low	$8M	$33M	$11M	$2M	$2M	$31M
High	$8M	$33M	$11M	$2M	$2M	$31M
EBITDA Avg	$-3M	$-14M	$-5M	$-833,154	$-833,154	$-13M
Low	$-3M	$-14M	$-5M	$-833,154	$-833,154	$-13M
High	$-3M	$-14M	$-5M	$-833,154	$-833,154	$-13M
EBIT Avg	$-3M	$-14M	$-5M	$-833,868	$-833,868	$-13M
Low	$-3M	$-14M	$-5M	$-833,868	$-833,868	$-13M
High	$-3M	$-14M	$-5M	$-833,868	$-833,868	$-13M
Net Income Avg	$-13M	$5M	$-11M	$-19M	$-19M	$5M
Low	$-13M	$5M	$-11M	$-19M	$-19M	$5M
High	$-13M	$5M	$-11M	$-19M	$-19M	$5M
EPS Avg	$-0.75	$0.28	$-0.64	$-1.14	$-1.14	$0.29
Low	$-0.75	$0.28	$-0.64	$-1.14	$-1.14	$0.29
High	$-0.75	$0.28	$-0.64	$-1.14	$-1.14	$0.29
Analysts (Rev / EPS)	2 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Jun 15, 2026Mizuho Securities

Assembly Biosciences price target raised to $45 from $40 at Mizuho

Target:$45.00

+96.0%from $22.96

Nov 20, 2025Mizuho Securities

Assembly Biosciences price target raised to $40 from $29 at Mizuho

Target:$40.00

+2.6%from $39.00

Sep 24, 2025JMP Securities

Assembly Biosciences initiated with an Outperform at Citizens JMP

Target:$38.00

+46.7%from $25.90

Sep 24, 2024Mizuho Securities

Mizuho Reiterates Outperform Rating on Assembly Biosciences (ASMB)

Target:$36.00

+121.4%from $16.26

Sep 20, 2024Jefferies

Jefferies Upgrades Assembly Biosciences (ASMB) to Buy

Target:$35.00

+89.2%from $18.50

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance